[go: up one dir, main page]

SE9702681D0 - Method and composition for treatment of impotence - Google Patents

Method and composition for treatment of impotence

Info

Publication number
SE9702681D0
SE9702681D0 SE9702681A SE9702681A SE9702681D0 SE 9702681 D0 SE9702681 D0 SE 9702681D0 SE 9702681 A SE9702681 A SE 9702681A SE 9702681 A SE9702681 A SE 9702681A SE 9702681 D0 SE9702681 D0 SE 9702681D0
Authority
SE
Sweden
Prior art keywords
impotence
treatment
composition
compositions
transurethral
Prior art date
Application number
SE9702681A
Other languages
English (en)
Swedish (sv)
Inventor
Johan Stjernschantz
Bahram Resul
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9702681A priority Critical patent/SE9702681D0/xx
Publication of SE9702681D0 publication Critical patent/SE9702681D0/xx
Priority to US09/462,450 priority patent/US6476074B1/en
Priority to JP2000501755A priority patent/JP2001509485A/ja
Priority to CA002295721A priority patent/CA2295721A1/en
Priority to AU83682/98A priority patent/AU752049B2/en
Priority to EP98934081A priority patent/EP1003520B1/en
Priority to PCT/SE1998/001367 priority patent/WO1999002164A1/en
Priority to DE69819515T priority patent/DE69819515T2/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9702681A 1997-07-10 1997-07-10 Method and composition for treatment of impotence SE9702681D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9702681A SE9702681D0 (sv) 1997-07-10 1997-07-10 Method and composition for treatment of impotence
US09/462,450 US6476074B1 (en) 1997-07-10 1998-07-10 Method and composition for treatment of erectile dysfunction
JP2000501755A JP2001509485A (ja) 1997-07-10 1998-07-10 勃起不全を処置するための方法および組成物
CA002295721A CA2295721A1 (en) 1997-07-10 1998-07-10 Method and composition for treatment of erectile dysfunction
AU83682/98A AU752049B2 (en) 1997-07-10 1998-07-10 Method and composition for treatment of erectile dysfunction
EP98934081A EP1003520B1 (en) 1997-07-10 1998-07-10 Hydroxy-prostaglandin derivatives for the treatment of erectile dysfunction
PCT/SE1998/001367 WO1999002164A1 (en) 1997-07-10 1998-07-10 Method and composition for treatment of erectile dysfunction
DE69819515T DE69819515T2 (de) 1997-07-10 1998-07-10 Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702681A SE9702681D0 (sv) 1997-07-10 1997-07-10 Method and composition for treatment of impotence

Publications (1)

Publication Number Publication Date
SE9702681D0 true SE9702681D0 (sv) 1997-07-10

Family

ID=20407719

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702681A SE9702681D0 (sv) 1997-07-10 1997-07-10 Method and composition for treatment of impotence

Country Status (8)

Country Link
US (1) US6476074B1 (xx)
EP (1) EP1003520B1 (xx)
JP (1) JP2001509485A (xx)
AU (1) AU752049B2 (xx)
CA (1) CA2295721A1 (xx)
DE (1) DE69819515T2 (xx)
SE (1) SE9702681D0 (xx)
WO (1) WO1999002164A1 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900025D0 (sv) * 1999-01-08 1999-01-08 Synphora Ab Method and composition for treatment of female sexual dysfunction
AU3713600A (en) 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
US6710081B1 (en) 1999-10-07 2004-03-23 Ono Pharmaceutical Co., Ltd. Erection insufficiency remedies
EP1108426A3 (en) * 1999-12-02 2002-10-02 Pfizer Products Inc. Use of prostaglandin agonists to treat erectile dysfunction or impotence
ATE327751T1 (de) 2000-01-31 2006-06-15 Pfizer Prod Inc Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz
FR2812192B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
EP1306087A4 (en) * 2000-07-31 2007-07-25 Ono Pharmaceutical Co MEDICAMENT FOR TREATING EFFECTS OF DISORDER CONTAINING PROSTAGLANDINE DERIVATIVES AS ACTIVE COMPONENTS
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
DE60221130T2 (de) 2001-07-16 2008-03-13 F. Hoffmann-La Roche Ag 2 pyrrolidon-derivate als prostanoid-agonisten
CA2454584C (en) 2001-07-23 2009-09-22 Ono Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient
AU2003233729B2 (en) * 2002-06-06 2007-10-04 Merck Frosst Canada Ltd 1,5-distributed pyrrolid-2-one derivatives for use as EP4 receptor agonists in the treatment of eye diseases such as glaucoma
PT1563846E (pt) 2002-10-10 2012-11-13 Ono Pharmaceutical Co Promotores da produção de factores endógenos de reparação
EP1603874B1 (en) 2003-03-03 2008-05-07 Laboratoires Serono SA G-lactam derivatives as prostaglandin agonists
CA2529123A1 (en) 2003-07-18 2005-02-10 Applied Research Systems Ars Holding N.V. Hydrazide derivatives as prostaglandin receptors modulators
JP5128954B2 (ja) 2004-12-06 2013-01-23 メルク セローノ ソシエテ アノニム Ｄｐ１受容体アゴニストとして使用されるピロリジン−２−オン誘導体
GB0501192D0 (en) 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
AU2007233212B2 (en) * 2006-04-04 2012-09-13 Allergan, Inc. Therapeutic prostaglandin compounds for the treatment of glaucoma
US8455547B2 (en) * 2008-02-05 2013-06-04 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
JP6400479B2 (ja) 2012-10-29 2018-10-03 株式会社カルディオ 肺疾患特異的治療剤
US9968716B2 (en) 2013-10-15 2018-05-15 Ono Pharmaceutical Co., Ltd. Drug-eluting stent graft
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190670A (en) * 1974-03-26 1980-02-26 Gist Brocades N.V. Prostaglandin derivatives
AU2300092A (en) * 1991-07-03 1993-02-11 Nathan E. Scott Prostaglandin e2 treatment of impotence
SE9403158D0 (sv) * 1994-09-21 1994-09-21 Pharmacia Ab New use of prostaglandins
US5741511A (en) 1995-04-12 1998-04-21 Sam Yang Co., Ltd. Transdermal drug delivery device for treating erectile dysfunction

Also Published As

Publication number Publication date
DE69819515T2 (de) 2004-09-23
EP1003520A1 (en) 2000-05-31
AU752049B2 (en) 2002-09-05
WO1999002164A1 (en) 1999-01-21
AU8368298A (en) 1999-02-08
JP2001509485A (ja) 2001-07-24
US6476074B1 (en) 2002-11-05
DE69819515D1 (de) 2003-12-11
CA2295721A1 (en) 1999-01-21
EP1003520B1 (en) 2003-11-05

Similar Documents

Publication Publication Date Title
SE9702681D0 (sv) Method and composition for treatment of impotence
HU0100495D0 (en) Use of prostaglandin (pge2)receptor 4 (ep4)selective agonists for the treatment of acute and chronic renal failure
TR199901669T2 (xx) Erkeklerdeki ereksiyon probleminin tedavisi i�in gerekli dozaj �ekilleri ve metod.
CO5680108A1 (es) Compuestos para el tratamiento de la disfuncion sexual femenina
AR002992A1 (es) Composicion farmaceutica para el tratamiento de la impotencia masculina o disminucion erectil y aplicacion de un nitrito organico con este fin.
DK1135153T3 (da) Anvendelser af EPH-receptorantagonister og -agonister til behandling af vaskulære forstyrrelser
EA200300387A1 (ru) Ингибиторы рецептора ep4 для лечения ревматоидного артрита
PT957914E (pt) Formulacao de agonistas de 5-ht
YU97902A (sh) Ciklopentanoindoli, smeše koje sadrže takva jedinjenja i metodi lečenja
UA41316C2 (uk) Трициклічні похідні піролу і фармацевтичний препарат
LV12125A (lv) Ciklofilina rotamazes aktivitates inhibitori
NO20001744L (no) FremgangsmÕter for Õ behandle psykose forbundet med glykokortikoidrelatert dysfunksjon
IS2882B (is) Samsetning epóþílonhliðstæðna og virkra efna til efnameðferðar til þess að meðhöndla frumufjölgunarsjúkdóma
EA199900045A1 (ru) Производные спиропиперидина и их использование в качестве терапевтических агентов
EA200200324A1 (ru) Способы применения селективных ингибиторов обратного захвата серотонина быстрого запуска для лечения половой дисфункции
ATE303804T1 (de) Behandlung von sexueller funktionsstörung mit bombesin rezeptor antagonisten
EA199900362A1 (ru) Новые соединения, полезные для использования в качестве нейрозащитных средств
DE60011748D1 (de) Methoden und zusammenstellungen zur behandlung der weiblichen sexuellen dysfunktion
EP1108426A3 (en) Use of prostaglandin agonists to treat erectile dysfunction or impotence
KR890011890A (ko) 약제학적 화합물
MXPA03004547A (es) Agonistas receptores de d4 de dopamina selectivos para el tratamiento de disfuncion sexual.
ATE473001T1 (de) Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba
EA200500452A1 (ru) Способы лечения эректильной дисфункции у мужчин
WO2002017963A3 (en) Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction
MY155220A (en) Selective dopamine d4 receptor agonists for treating sexual dysfunction